Proton and sodium 23 magnetic resonance imaging of human ocular tissues. A model study.

Arch Ophthalmol

Howe Laboratory of Ophthalmology, Massachusetts Eye and Ear Infirmary,Boston 02114.

Published: November 1987

Clinical evaluation of uveal melanomas by magnetic resonance imaging (MRI) techniques depends on developing an understanding of the appearance of these tumors in magnetic resonance (MR) images. We have determined MR characteristics of uveal melanomas by proton (1H) and sodium 23 MRI of freshly enucleated human eyes at 1.5 tesla. The MR images were obtained using two-turn proton and 23Na surface coils, designed to both transmit and receive the radiofrequency signal. Proton MRI techniques included saturation recovery and spin echo; the gradient-recalled echo technique was used for 23Na MRI. Proton and 23Na MR images provide complementary information; contrast between intraocular tumors and vitreous, lens, or subretinal hemorrhage may be varied by using MR pulse sequences that emphasize tissues based on T1, T2, proton, or sodium density values. A combination of proton and 23Na MRI provides differentiation between normal ocular structures and intraocular tumors, as well as associated complications, such as retinal detachments and subretinal hemorrhages.

Download full-text PDF

Source
http://dx.doi.org/10.1001/archopht.1987.01060110078036DOI Listing

Publication Analysis

Top Keywords

proton sodium
12
magnetic resonance
12
proton 23na
12
resonance imaging
8
uveal melanomas
8
mri techniques
8
23na mri
8
intraocular tumors
8
proton
7
mri
5

Similar Publications

We report the rapid synthesis of primary amides by directly using commercially available ammonia borane (NH·BH), sodium hexamethyldisilazide (NaHMDS), and esters. The success of this protocol relies on NH·BH as the nitrogen source being considerably more convenient and NaHMDS being an excellent proton abstractor but not participating in the nucleophilic addition reaction. The reaction had a wide substrate scope containing bioactive molecules, and most of the substrates were efficiently amidated over 90% yields.

View Article and Find Full Text PDF

The misuse and uncontrolled release of pharmaceuticals into water bodies lead to environmental challenges and the development of resistance, thereby reducing their effectiveness. To mitigate these problems, it is essential to identify pharmaceuticals in water sources and eliminate them prior to human use. This study presents the designing of a novel nanosensor for the detection of the antibiotic Cefoperazone Sodium Sulbactam Sodium (CSSS).

View Article and Find Full Text PDF

We investigated the gas-liquid interface of aqueous solutions containing phenol and related aromatic compounds using extreme ultraviolet laser photoelectron spectroscopy and molecular dynamics simulations. The interfacial densities of protonated and deprotonated forms of phenol, aniline, and 4-nitrophenol were found to be primarily determined by their surface affinities and exhibit similar concentration dependences to their respective bulk densities. Despite the distinct interfacial orientations of their permanent dipole moments, these compounds monotonically decreased the surface potential at higher concentrations.

View Article and Find Full Text PDF

Enhanced room temperature ammonia gas sensing based on a multichannel PSS-functionalized graphene/PANI network.

Analyst

January 2025

Guangdong Provincial Key Laboratory of Electronic Functional Materials and Devices, Huizhou University, Huizhou, 516007, China.

Disordered polymerization of polymers widens the polymerization degree distribution, which leads to uncontrollable thickness and significantly weakens their sensing performance. Herein, poly(sodium -styrenesulfonate)-functionalized reduced graphene oxide (PSS-rGO) with multichannel chain structures coated with thin polyaniline layer (PSS-rGO/PANI) nanocomposites was synthesized a facile interfacial polymerization route. The morphology and microstructure of the PSS-rGO/PANI nanocomposites were characterized using Fourier transform infrared (FTIR) spectroscopy, Raman spectroscopy, X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), and scanning electron microscopy (SEM).

View Article and Find Full Text PDF

Tenapanor: A novel therapeutic agent for dialysis patients with hyperphosphatemia.

Ther Apher Dial

January 2025

Division of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.

Patients on dialysis often develop hyperphosphatemia, contributing to an increased risk of cardiovascular events and mortality. Currently, several types of phosphate binders (PBs) exist for the treatment of hyperphosphatemia, but they are sometimes associated with drug-specific side effects and high pill burden, making it difficult to control serum phosphorus appropriately. Tenapanor, which has a novel mechanism to reduce serum phosphorus via selective sodium/proton exchange transporter 3 inhibition, was approved for hyperphosphatemia in Japan in 2023.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!